FindTrial
Sign In

Infanrix

BIOLOGICAL9 trials

Sponsors

GlaxoSmithKline, American SIDS Institute, Pfizer

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHealthyHepatitis BInfections, PapillomavirusInfections, RotavirusPoliomyelitis

Phase 2

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
CompletedNCT00729001
GlaxoSmithKlineInfections, Rotavirus
Start: 2000-11-30End: 2002-09-30Updated: 2016-09-16

Phase 3

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines
CompletedNCT00148941
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2005-01-06End: 2006-12-04Updated: 2020-02-05
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
CompletedNCT00412854
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2007-01-03End: 2007-06-25Updated: 2018-06-06
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
CompletedNCT01627561
GlaxoSmithKlineInfections, Papillomavirus
Start: 2012-10-15End: 2016-10-06Updated: 2020-04-10
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
CompletedNCT02096263
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3
Start: 2014-04-16End: 2015-11-13Updated: 2019-11-27
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
RecruitingNCT07160244
PfizerHealthy
Start: 2025-08-25End: 2029-03-02Target: 6000Updated: 2026-02-04

Phase 4

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
TerminatedNCT00544271
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2003-05-31End: 2004-01-31Updated: 2016-09-07

Unknown Phase

DTaP and Apnea/Bradycardia in Preterm Infants
CompletedNCT00482781
American SIDS InstituteProlonged Apnea, Prolonged Bradycardia
Start: 2000-09-30End: 2004-09-30Updated: 2007-06-05
Duration of Protection: GSK DTaP Vaccines
CompletedNCT02447978
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2015-02-28End: 2015-06-30Updated: 2015-11-02

Related Papers

Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls
The Pediatric Infectious Disease Journal2019-08-3014 citations
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and <i>Haemophilus influenzae</i> type b vaccine: a randomized trial in the United States
Human Vaccines & Immunotherapeutics2018-11-2016 citations
Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4-6-year-old Girls: Results to Month 12 From a Randomized Trial.
2018-04-017 citations
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine
Vaccine2017-05-1342 citations
Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, <i>Rotarix</i>™: A retrospective laboratory analysis
Human Vaccines & Immunotherapeutics2016-09-228 citations